JP2024522193A5 - - Google Patents

Info

Publication number
JP2024522193A5
JP2024522193A5 JP2023576010A JP2023576010A JP2024522193A5 JP 2024522193 A5 JP2024522193 A5 JP 2024522193A5 JP 2023576010 A JP2023576010 A JP 2023576010A JP 2023576010 A JP2023576010 A JP 2023576010A JP 2024522193 A5 JP2024522193 A5 JP 2024522193A5
Authority
JP
Japan
Prior art keywords
antigen
influenza virus
seq
immune response
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576010A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522193A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/032799 external-priority patent/WO2022261297A2/en
Publication of JP2024522193A publication Critical patent/JP2024522193A/ja
Publication of JP2024522193A5 publication Critical patent/JP2024522193A5/ja
Pending legal-status Critical Current

Links

JP2023576010A 2021-06-10 2022-06-09 免疫原としての広範囲反応性ウイルス抗原、その組成物及び使用方法 Pending JP2024522193A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163209209P 2021-06-10 2021-06-10
US63/209,209 2021-06-10
PCT/US2022/032799 WO2022261297A2 (en) 2021-06-10 2022-06-09 Broadly reactive viral antigens as immunogens, compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024522193A JP2024522193A (ja) 2024-06-11
JP2024522193A5 true JP2024522193A5 (https=) 2025-10-29

Family

ID=84426405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576010A Pending JP2024522193A (ja) 2021-06-10 2022-06-09 免疫原としての広範囲反応性ウイルス抗原、その組成物及び使用方法

Country Status (7)

Country Link
US (1) US20240100148A1 (https=)
EP (1) EP4351637A4 (https=)
JP (1) JP2024522193A (https=)
CN (1) CN117693359A (https=)
AU (1) AU2022289009A1 (https=)
CA (1) CA3221953A1 (https=)
WO (1) WO2022261297A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025038695A1 (en) * 2023-08-14 2025-02-20 The Wistar Institute Of Anatomy And Biology Modified h3 hemagglutinin antigens and methods of use thereof
WO2025179103A1 (en) * 2024-02-23 2025-08-28 University Of Georgia Research Foundation, Inc. Pentavalent and octavalent influenza virus immunogens, compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120219584A1 (en) * 2009-10-05 2012-08-30 The United States Of America As Represented By The Secretary, Department Of Health Protection against pandemic and seasonal strains of influenza
CA2970158A1 (en) * 2014-12-19 2016-06-23 Oregon Health & Science University Synergistic co-administration of computationally optimized broadly reactive antigens for h1n1 influenza
WO2017053374A1 (en) * 2015-09-21 2017-03-30 Oregon Health & Science University Design and characterization of influenza vaccines
US20200237898A1 (en) * 2015-09-21 2020-07-30 Oregon Health & Science University Vaccines intelligently produced by epitope recombination (viper) for influenza
WO2020092207A1 (en) * 2018-10-28 2020-05-07 University Of Georgia Research Foundation Broadly reactive immunogens of influenza virus, compositions, and methods of use thereof
WO2020172365A1 (en) * 2019-02-21 2020-08-27 University Of Georgia Research Foundation Broadly reactive immunogens of h5 influenza virus, compositions and methods of use thereof
US20220204567A1 (en) * 2019-04-25 2022-06-30 Janssen Vaccines & Prevention B.V. Recombinant influenza antigens

Similar Documents

Publication Publication Date Title
US12005111B2 (en) Zika virus vaccine
US12239699B2 (en) Immunogen for broad-spectrum influenza vaccine and application thereof
US7504107B2 (en) Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
TWI688652B (zh) 作為對抗腸病毒感染之免疫原的病毒顆粒及其製造
JP2024522193A5 (https=)
RU2008102930A (ru) Способы введения вакцин, новые калицивирусы кошки и варианты лечения для иммунизации животных против парвовируса кошки и вируса герпеса кошки
CN102399757A (zh) 免疫原性组合物及其用途
CN112691189A (zh) 一种猫传染性腹膜炎病毒亚单位疫苗及应用
JP2023522154A5 (https=)
JP2022521410A5 (https=)
AU2016313660B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
JP2014502143A5 (https=)
Lim et al. RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform
CN1338310A (zh) 一种猪瘟病毒表位疫苗及其制备方法
JP2022513438A5 (https=)
CN110204613B (zh) 一种针对胡宁病毒的中和抗体、其制备方法及其应用
RU2442604C1 (ru) Способ усиления иммунного ответа
KR101302245B1 (ko) 넓은 범위의 교차 방어능력을 갖는 신규한 보강 인플루엔자 백신
KR20240051039A (ko) 인플루엔자 A 바이러스 항원 단백질 HA, NA 또는 M2e5x를 포함하는 바이러스 유사입자 조합 백신
Zhang et al. Severe acute respiratory syndrome: vaccine on the way
WO2023102483A1 (en) Immunogens targeting anthrax
HK40098392A (en) Zika virus vaccine
CA2996497C (en) Polypeptide carrier for presenting target polypeptide and uses thereof
JP2024518565A (ja) 組換え重複ペプチド及びネイティブタンパク質を含むワクチン製剤
CN119264229A (zh) 基于SARS-CoV-2的不同奥密克戎变异型的S蛋白的疫苗和组合物